Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🇺🇸 FDA

mRNA-1345 News

🇺🇸 FDA ← All news

FDA mRNA-1345 coverage for business development, investment, and market access teams

High impact AnalysisApr 26, 2026

FDA Approval mRNA Vaccine RSV: Market Impact & Future Outlook

FDA · Infectious Diseases · 4 min

Dr. Priya Nandakumar
High impact AnalysisApr 24, 2026

FDA Approval ResVax: Comprehensive Market Analysis of Novel mRNA RSV Vaccine

FDA · Respiratory Syncytial Virus (RSV) prevention · 8 min

Dr. Hannah O'Connor
High impact NewsApr 7, 2026

FDA Approves Moderna RSV Vaccine mRNA-1345 for Older Adults

FDA · Infectious Disease · 6 min

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.